Japanese Simple Chinese Traditional Chinese Korean 

Conference Menu

Current Event 

Day 1
Day 2
Day 3
PDF Download
Short Course
Delegate List
Hotel & Travel
Sponsor & Exhibits
Press Pass 
Request Brochure 

Chemical Computing Group 



Reaction Biology 


Vlife Logo 

Intelligent Pharma 



Insight Pharma Reports 

Science AAAS logo 

The Scientist 

chemical biology 



Markets and Markets logo 

Reports and Reports 

CanBiotech logo 



Pharm Cast 

SelectScience logo 


Therapeutic Target Space:
Methods for Druggability Assessment


  • W. Patrick Walters, Ph.D., Senior Research Fellow, Group Head, Computational Drug Discovery Technologies, Vertex Pharmaceuticals, Inc. 
  • Tomi Sawyer, Ph.D., Chief Scientific Officer, AILERON Therapeutics; Editor-in-Chief, Chemical Biology & Drug Design 
  • Gergely Toth, Ph.D., University of Cambridge, UK 
  • David Dalgarno, Ph.D., Vice President, Research Technologies, ARIAD Pharmaceuticals, Inc. 
  • José Duca, Ph.D., Senior Principal Scientist, 3D - Drug Design Department, Merck Research Laboratories 
  • Raymond C. Stevens, Ph.D., Professor, Departments of Molecular Biology and Chemistry, Scripps Research Institute  



  • D. R. Artis, Ph.D., Senior Vice President, Global Research, Elan Pharmaceuticals, Inc. 
  • Talapady Bhat, Ph.D., Project Leader, Biochemical Science, NIST 
  • Natasja Brooijmans, Ph.D., Principal Research Scientist, Computational Chemistry & Cheminformatics, Pfizer, Inc. 
  • Stefano Costanzi, Ph.D., Head of the Molecular Modeling Unit, Laboratory Biological Modeling, NIDDK, National Institutes of Health 
  • David Dalgarno, Ph.D., Vice President, Research Technologies, ARIAD Pharmaceuticals, Inc. 
  • Rajarshi Guha, Ph.D., Research Scientist, Informatics, NIH Chemical Genomics Center 
  • Michael Hanson, Ph.D., Associate Director, Structural Biology, Receptos, Inc. 
  • Roderick Hubbard, Ph.D., Professor and Senior Fellow, Structural Sciences, University of York and Vernalis 
  • Rama Kondru, Ph.D., Principal Research Scientist, Discovery Chemistry, Hoffmann-La Roche 
  • Andreas Kuglstatter, Ph.D., Research Scientist, Discovery Technologies, Roche 
  • Ryan Lilien, Ph.D., M.D., Assistant Professor, Department of Computer Science and Banting & Best Department of Medical Research, Faculty of Medicine, University of Toronto 
  • Jody Mason, Ph.D., Lecturer, Biological Sciences, University of Essex 
  • Jonathan Mason, Ph.D., Head of Computational Chemistry / Chief Scientist, Medicinal Chemistry, Heptares Therapeutic Ltd / Lundbeck Resesrch DK 
  • Nicolas Moitessier, Ph.D., Professor, Chemistry, McGill University 
  • Xavier Morelli, Ph.D., Group Leader, Drug Design, CNRS/ IMR Laboratory 
  • Paul Mortenson, Ph.D., Senior Research Associate, Computational Chemistry and Informatics, Astex Therapeutics Ltd. 
  • Deqiang Niu, Ph.D., Principal Scientist/Project Leader, Medicinal Chemistry, Avila Therapeutics 
  • Emanuele Perola, Ph.D., Research Fellow, Computational Drug Discovery Technologies, Vertex Pharmaceuticals, Inc. 
  • Matthias Rarey, Ph.D., Professor & Managing Director, ZBH Center for Bioinformatics, University of Hamburg 
  • Alan Rigby, Ph.D., Assistant Professor of Medicine, Harvard Medical School; Director, Program in Drug Discovery and Target Validation, Beth Israel Deaconess Medical Center 
  • Tomi Sawyer, Ph.D., Chief Scientific Officer, AILERON Therapeutics; Editor-in-Chief, Chemical Biology & Drug Design 
  • Celia Schiffer, Ph.D., Professor, Biochemistry & Molecular Pharmacology, UMass Medical School 
  • Woody Sherman, Ph.D., Vice President, Applications Science, Schrodinger, Inc. 
  • Juswinder Singh, Ph.D., Co-Founder/Chief Scientific Officer, Avila Therapeutics 
  • Sid Topiol, Ph.D., Head of US Computational Chemistry and Structural Investigations, Lundbeck Research, USA 
  • Chris Williams, Ph.D., Principal Scientist, Chemical Computing Group (CCG) 
  • Jeffrey S. Wiseman, Ph.D., CEO and Co-Founder, Pharmatrope, Ltd. 
  • Jie Zheng, Ph.D., Associate Member, Department of Structural Biology, St. Jude Children's Research Hospital